|
1
|
Bristow MR, Ginsburg R, Umans V, Fowler M,
Minobe W, Rasmussen R, Zera P, Menlove R, Shah P and Jamieson S:
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing
and failing human ventricular myocardium: coupling of both receptor
subtypes to muscle contraction and selective beta 1-receptor
down-regulation in heart failure. Circ Res. 59:297–309. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Engelhardt S, Böhm M, Erdmann E and Lohse
MJ: Analysis of beta-adrenergic receptor mRNA levels in human
ventricular biopsy specimens by quantitative polymerase chain
reactions: progressive reduction of beta 1-adrenergic receptor mRNA
in heart failure. J Am Coll Cardiol. 27:146–154. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miao G, Chen Z, Fang X, Liu M, Hao G, An
H, Zhang Z, Lu L, Zhang J and Zhang L: Relationship between the
autoantibody and expression of β3-adrenoceptor in lung and heart.
PLoS One. 8:e687472013. View Article : Google Scholar
|
|
4
|
Grossini E, Surico D, Mary DA, Molinari C,
Surico N and Vacca G: In anesthetized pigs human chorionic
gonadotropin increases myocardial perfusion and function through a
β-adrenergic-related pathway and nitric oxide. J Appl Physiol
(1985). 115(4): 422–35. 2013. View Article : Google Scholar
|
|
5
|
Mak JC, Nishikawa M, Haddad EB, Kwon OJ,
Hirst SJ, Twort CH and Barnes PJ: Localisation and expression of
beta-adrenoceptor subtype mRNAs in human lung. Eur J Pharmacol.
302:215–221. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rinaldi B, Capuano A, Gritti G, Donniacuo
M, Scotto Di Vettimo A, Sodano L, Rafaniello C, Rossi F and Matera
MG: Effects of chronic administration of β-blockers on airway
responsiveness in a murine model of heart failure. Pulm Pharmacol
Ther. 28:109–113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Horn MA, Graham HK, Richards MA, Clarke
JD, Greensmith DJ, Briston SJ, Hall MC, Dibb KM and Trafford AW:
Age-related divergent remodeling of the cardiac extracellular
matrix in heart failure: collagen accumulation in the young and
loss in the aged. J Mol Cell Cardiol. 53:82–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iwata M, Yoshikawa T, Baba A, Anzai T,
Nakamura I, Wainai Y, Takahashi T and Ogawa S: Autoimmunity against
the second extracellular loop of beta(1)-adrenergic receptors
induces beta-adrenergic receptor desensitization and myocardial
hypertrophy in vivo. Circ Res. 88:578–586. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jahns R, Boivin V, Hein L, Triebel S,
Angermann CE, Ertl G and Lohse MJ: Direct evidence for a beta
1-adrenergic receptor-directed autoimmune attack as a cause of
idiopathic dilated cardiomyopathy. J Clin Invest. 113:1419–1429.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aso S, Yazaki Y, Kasai H, Takahashi M,
Yoshio T, Yamamoto K and Ikeda U: Anti-beta 1-adrenoreceptor
autoantibodies and myocardial sympathetic nerve activity in chronic
heart failure. Int J Cardiol. 131:240–245. 2009. View Article : Google Scholar
|
|
11
|
Staudt Y, Mobini R, Fu M, Felix SB, Kühn
JP and Staudt A: Beta1-adrenoceptor antibodies induce apoptosis in
adult isolated cardiomyocytes. Eur J Pharmacol. 466:1–6. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng QZ, Zhao YS and Abdelwahid E: The
role of Fas in the progression of ischemic heart failure:
prohypertrophy or proapoptosis. Coron Artery Dis. 19:527–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Adamopoulos S, Parissis J, Karatzas D,
Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou
K, Coats AJ and Kremastinos DT: Physical training modulates
proinflammatory cytokines and the soluble Fas/soluble Fas ligand
system in patients with chronic heart failure. J Am Coll Cardiol.
39:653–663. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kinugawa T, Kato M, Yamamoto K, Hisatome I
and Nohara R: Proinflammatory cytokine activation is linked to
apoptotic mediator, soluble Fas level in patients with chronic
heart failure. Int Heart J. 53:182–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown RH, Walters DM, Greenberg RS and
Mitzner W: A method of endotracheal intubation and pulmonary
functional assessment for repeated studies in mice. J Appl Physiol
(1985). 87:2362–2365. 1999.
|
|
16
|
Chen Z, Miao G, Liu M, Hao G, Liu Y, Fang
X, Zhang Z, Lu L, Zhang J and Zhang L: Age-related up-regulation of
beta3-adrenergic receptor in heart-failure rats. J Recept Signal
Transduct Res. 30:227–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Borst MM, Beuthien W, Schwencke C, LaRosée
P, Marquetant R, Haass M, Kübler W and Strasser RH: Desensitization
of the pulmonary adenylyl cyclase system: a cause of airway
hyperresponsiveness in congestive heart failure? J Am Coll Cardiol.
34:848–856. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carstairs JR, Nimmo AJ and Barnes PJ:
Autoradiographic visualization of beta-adrenoceptor subtypes in
human lung. Am Rev Respir Dis. 132:541–547. 1985.PubMed/NCBI
|
|
19
|
Agostoni P, Contini M, Cattadori G,
Apostolo A, Sciomer S, Bussotti M, Palermo P and Fiorentini C: Lung
function with carvedilol and bisoprolol in chronic heart failure:
is beta selectivity relevant? Eur J Heart Fail. 9:827–833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ruffin RE, McIntyre EL, Latimer KM, Ward
HE, Crockett AJ and Alpers JH: Assessment of beta-adrenoceptor
antagonists in asthmatic patients. Br J Clin Pharmacol. 13(Suppl
2): 325S–335S. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakuma T, Tuchihara C, Ishigaki M, Osanai
K, Nambu Y, Toga H, Takahashi K, Ohya N, Kurihara T and Matthay MA:
Denopamine, a beta(1)-adrenergic agonist, increases alveolar fluid
clearance in ex vivo rat and guinea pig lungs. J Appl Physiol
(1985). 90:10–6. 2001.
|
|
22
|
Lasnier JM, Wangensteen OD, Schmitz LS,
Gross CR and Ingbar DH: Terbutaline stimulates alveolar fluid
resorption in hyperoxic lung injury. J Appl Physiol (1985). 81(4):
1723–9. 1996.
|
|
23
|
Liu J, Wang Y, Chen M, Zhao W, Wang X,
Wang H, Zhang Z, Zhang J, Xu L, Chen J, et al: The correlation
between peripartum cardiomyopathy and autoantibodies against
cardiovascular receptors. PLoS One. 9:e867702014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshikawa T, Baba A and Nagatomo Y:
Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J.
73:602–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagatomo Y, Yoshikawa T, Okamoto H,
Kitabatake A and Hori M; Japanese Chronic Heart Failure Study
Investigators: Presence of autoantibody directed against
β1-adrenergic receptors is associated with amelioration of cardiac
function in response to carvedilol: Japanese chronic heart failure
(J-CHF) study. J Card Fail. 21:198–207. 2015. View Article : Google Scholar
|
|
26
|
Stavrakis S, Kem DC, Patterson E, Lozano
P, Huang S, Szabo B, Cunningham MW, Lazzara R and Yu X: Opposing
cardiac effects of autoantibody activation of β-adrenergic and M2
muscarinic receptors in cardiac-related diseases. Int J Cardiol.
148:331–336. 2011. View Article : Google Scholar
|
|
27
|
Sterin-Borda L, Gorelik G, Postan M,
Gonzalez Cappa S and Borda E: Alterations in cardiac
beta-adrenergic receptors in chagasic mice and their association
with circulating beta-adrenoceptor-related autoantibodies.
Cardiovasc Res. 41:116–125. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lohse MJ, Engelhardt S and Eschenhagen T:
What is the role of beta-adrenergic signaling in heart failure?
Circ Res. 93:896–906. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu HR, Zhao RR, Jiao XY, Wang YY and Fu
M: Relationship of myocardial remodeling to the genesis of serum
autoantibodies to cardiac beta(1)-adrenoceptors and muscarinic type
2 acetyl-choline receptors in rats. J Am Coll Cardiol.
39:1866–1873. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tanaka M, Suda T, Yatomi T, Nakamura N and
Nagata S: Lethal effect of recombinant human Fas ligand in mice
pretreated with Propionibacterium acnes. J Immunol. 158:2303–2309.
1997.PubMed/NCBI
|
|
31
|
Vasudevan SS, Lopes NH, Seshiah PN, Wang
T, Marsh CB, Kereiakes DJ, Dong C and Goldschmidt-Clermont PJ:
Mac-1 and Fas activities are concurrently required for execution of
smooth muscle cell death by M-CSF-stimulated macrophages.
Cardiovasc Res. 59:723–733. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Takemura G, Kosai K, Takahashi T,
Okada H, Miyata S, Yuge K, Nagano S, Esaki M, Khai NC, et al:
Critical roles for the Fas/Fas ligand system in postinfarction
ventricular remodeling and heart failure. Circ Res. 95:627–636.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Communal C, Colucci WS and Singh K: p38
mitogen-activated protein kinase pathway protects adult rat
ventricular myocytes against beta-adrenergic receptor-stimulated
apoptosis. Evidence for Gi-dependent activation. J Biol Chem.
275:19395–19400. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jane-wit D, Altuntas CZ, Johnson JM, Yong
S, Wickley PJ, Clark P, Wang Q, Popović ZB, Penn MS, Damron DS, et
al: Beta 1-adrenergic receptor autoantibodies mediate dilated
cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
Circulation. 116:399–410. 2007. View Article : Google Scholar : PubMed/NCBI
|
